DD9688A - - Google Patents

Info

Publication number
DD9688A
DD9688A DD9688DA DD9688A DD 9688 A DD9688 A DD 9688A DD 9688D A DD9688D A DD 9688DA DD 9688 A DD9688 A DD 9688A
Authority
DD
German Democratic Republic
Application number
Publication of DD9688A publication Critical patent/DD9688A/xx

Links

DD9688D DD9688A (OSRAM)

Publications (1)

Publication Number Publication Date
DD9688A true DD9688A (OSRAM)

Family

ID=222111

Family Applications (1)

Application Number Title Priority Date Filing Date
DD9688D DD9688A (OSRAM)

Country Status (1)

Country Link
DD (1) DD9688A (OSRAM)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1243583A4 (en) * 1999-12-28 2003-08-20 Eisai Co Ltd HETEROCYCLIC COMPOUNDS WITH SULFONAMIDE GROUPS
WO2008147797A3 (en) * 2007-05-25 2009-07-09 Vertex Pharma Ion channel modulators and methods of use
WO2009068468A3 (en) * 2007-11-30 2010-04-22 F. Hoffmann-La Roche Ag Pyridine compounds

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1243583A4 (en) * 1999-12-28 2003-08-20 Eisai Co Ltd HETEROCYCLIC COMPOUNDS WITH SULFONAMIDE GROUPS
WO2008147797A3 (en) * 2007-05-25 2009-07-09 Vertex Pharma Ion channel modulators and methods of use
WO2009068468A3 (en) * 2007-11-30 2010-04-22 F. Hoffmann-La Roche Ag Pyridine compounds
US8163778B2 (en) 2007-11-30 2012-04-24 Hoffmann-La Roche Inc. Pyridines as FBPase inhibitors for treatment of diabetes

Similar Documents

Publication Publication Date Title
AU653760B2 (en) Azole derivatives, process for their preparation, and their use
US8163778B2 (en) Pyridines as FBPase inhibitors for treatment of diabetes
DD9688A (OSRAM)